Evogene Statistics
NASDAQ: EVGNIndustrialsAgricultural ChemicalsUSD
0.4106-0.0131 (-3.09%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
Evogene by the numbers
Evogene has a market capitalization of $6.5 million based on 15.80M shares outstanding. With trailing EPS of $-1.60, Evogene is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 21.4% below its 50-day average and 43.4% below its 200-day average.
Average daily trading volume is 2.02M shares, or about $830,149 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
EVGN valuation vs. peer median
| Metric | EVGN | Peer median | Difference |
|---|---|---|---|
| Market cap | $6.49M | $21.35M | -70% |
| Avg. volume | 2.02M | 650.67K | +211% |
Peer median across 8 companies: SNES, NXTS, FRTT, ICL, BIOX, AVD, SMG, MOS.
Valuation
- Market cap
- $6.49M
- EPS (TTM)
- $-1.60
- Shares outstanding
- 15.80M
Price and trading
- Previous close
- 0.4237
- Open
- 0.429
- Day range
- 0.391 – 0.429
- 52-week range
- 0.35 – 1.50
- 50-day moving average
- 0.5226
- 200-day moving average
- 0.7251
- Beta
- —
- Volume
- 82.22K
- Average volume
- 2.02M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Aug 18, 2026
Additional statistics
- Market Cap
- 6.49M
- Forward Pe
- -0.68
- Eps
- -1.60
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 1.50
- Week52 Low
- 0.35
- Avg Volume
- 2.02M
- Shares Outstanding
- 15.80M
- Ma50
- 0.52
- Ma200
- 0.73
- Earnings Date
- Aug 18, 2026
- Pct From52w High
- -72.63%
- Pct From52w Low
- 17.31%